Additional Details

  • Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

    aTyr Investigative Site
    Chicago IL. 60611
    View Details

  • Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

    aTyr Investigative Site
    Dickson TN. 37055
    View Details

  • Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

    aTyr Investigative Site
    Portland OR. 97220
    View Details

  • Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

    aTyr Investigative Site
    Baltimore MD. 21224
    View Details

  • Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

    aTyr Investigative Site
    Richmond VA. 23298
    View Details

  • Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

    aTyr Investigative Site
    Birmingham AL. 35294
    View Details

  • Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

    aTyr Investigative Site
    Greenville NC. 27834
    View Details

  • Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

    aTyr Investigative Site
    Oklahoma City OK. 73104
    View Details

  • Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

    aTyr Investigative Site
    Charleston SC. 29425-0630
    View Details

  • Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

    aTyr Investigative Site
    Gainesville FL. 32610
    View Details

  • Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

    aTyr Investigative Site
    Rochester MN. 55905
    View Details

  • Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

    aTyr Investigative Site
    Cleveland OH. 44195
    View Details

  • Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

    aTyr Investigative Site
    New Orleans LA. 70115
    View Details

  • Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis

    Temple University, Dept of Thoracic Medicine & Surgery (TMS)
    Philadelphia PA. 19140
    View Details

  • Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis

    University of Southern California - Center for Advanced Lung Disease
    Los Angeles CA. 90033
    View Details

  • Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis

    Baylor Clinic
    Houston TX. 77030
    View Details

  • Atezolizumab for Idiopathic Pulmonary Fibrosis

    Cedars-Sinai Medical Center
    Los Angeles CA. 90048
    View Details

  • To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

    Premier Pulmonary Critical Care & Sleep Medicine
    Denison TX. 75020
    View Details

  • To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

    Southern Arizona VA Health Care System - NAVREF - PPDS
    Tucson AZ. 85723-0001
    View Details

  • To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

    Medical University of South Carolina
    Charleston SC. 29425-8900
    View Details